secwatch / observer
8-K filed November 9, 2023, 6:59 PM ET ticker AVAH CIK 0001832332
earnings confidence high sentiment neutral materiality 0.75

Aveanna Q3 revenue up 7.9% to $478M; net loss $102.4M on $105.1M impairment; raises FY guidance

Aveanna Healthcare Holdings, Inc.

2023-Q3 EPS reported -$0.57 revenue$1,416,368,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Aveanna Healthcare Holdings, Inc. reported three and nine-month periods ended September 30, 2023 results: revenue $478.0 million, net income Net loss was $102.4 million, EPS Net loss per diluted share was $(0.54). Guidance raised.

Period
three and nine-month periods ended September 30, 2023
Revenue
$478.0 million
Net income
Net loss was $102.4 million
EPS
Net loss per diluted share was $(0.54)
Guidance
raised
Result
reported results
Exact text from the filing
by reference in this Item 2.02. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES THIRD QUARTER 2023 FINANCIAL RESULTS • Revenue was $478.0 million, a 7.9% increase over the prior year o Gross margin increased 9.4% to $147.3 million, compared to Q3 2022 • Net loss was $102.4 million, inclusive of a $105.1 million non-cash
View on SEC.gov

Browse all earnings releases →

Aveanna Healthcare Holdings, Inc. filing history →

Source: SEC EDGAR
accession 0000950170-23-061483
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.